These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 12725708)

  • 1. Effects of rapid-acting insulin analogs on overall glycemic control in type 1 and type 2 diabetes mellitus.
    Ristic S; Bates PC
    Diabetes Technol Ther; 2003; 5(1):57-66. PubMed ID: 12725708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biosynthetic Human Insulin and Insulin Analogs.
    Rodbard HW; Rodbard D
    Am J Ther; 2020; 27(1):e42-e51. PubMed ID: 31876563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin lispro: its role in the treatment of diabetes mellitus.
    Campbell RK; Campbell LK; White JR
    Ann Pharmacother; 1996 Nov; 30(11):1263-71. PubMed ID: 8913409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [An update on multiple insulin injection therapy in type 1 and 2 diabetes].
    Varanauskiene E; Varanauskaite I; Ceponis J
    Medicina (Kaunas); 2006; 42(9):770-9. PubMed ID: 17028476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid- and high-ratio premix insulin analogues: potential treatment options for patients with type 2 diabetes in need of greater postprandial blood glucose control.
    Christiansen JS; Liebl A; Davidson JA; Ligthelm RJ; Halimi S
    Diabetes Obes Metab; 2010 Feb; 12(2):105-14. PubMed ID: 19895637
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Parental preference of prandial insulin aspart compared with preprandial human insulin in a basal-bolus scheme with NPH insulin in a 12-wk crossover study of preschool children with type 1 diabetes.
    Danne T; Råstam J; Odendahl R; Näke A; Schimmel U; Szczepanski R; Moeller J; Deiss D
    Pediatr Diabetes; 2007 Oct; 8(5):278-85. PubMed ID: 17850471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged efficacy of short acting insulin Lispro in combination with human ultralente in insulin-dependent diabetes mellitus.
    Burge MR; Waters DL; Holcombe JH; Schade DS
    J Clin Endocrinol Metab; 1997 Mar; 82(3):920-4. PubMed ID: 9062507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections.
    Bode BW
    Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unresolved challenges with insulin therapy in type 1 and type 2 diabetes: potential benefit of replacing amylin, a second beta-cell hormone.
    Edelman SV; Weyer C
    Diabetes Technol Ther; 2002; 4(2):175-89. PubMed ID: 12079621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
    Catargi B; Breilh D; Roger P; Tabarin A
    Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New options in insulin therapy.
    Schmid H
    J Pediatr (Rio J); 2007 Nov; 83(5 Suppl):S146-55. PubMed ID: 18038020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching to multiple daily injection therapy with glulisine improves glycaemic control, vascular damage and treatment satisfaction in basal insulin glargine-injected diabetic patients.
    Yanagisawa K; Ashihara J; Obara S; Wada N; Takeuchi M; Nishino Y; Maeda S; Ishibashi Y; Yamagishi S
    Diabetes Metab Res Rev; 2014 Nov; 30(8):693-700. PubMed ID: 24639403
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus.
    Kinsley B
    Clin Ther; 2007; 29 Suppl D():S153-60. PubMed ID: 18191067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhaled human insulin.
    Strack TR
    Drugs Today (Barc); 2006 Apr; 42(4):207-21. PubMed ID: 16703118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin glulisine.
    Cox SL
    Drugs Today (Barc); 2005 Jul; 41(7):433-40. PubMed ID: 16193096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-acting insulin analogs: progressing slowly].
    Holleman F; Hoekstra JB
    Ned Tijdschr Geneeskd; 2004 Aug; 148(34):1668-9. PubMed ID: 15453117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 18. New Insulins and New Aspects in Insulin Delivery.
    Woo VC
    Can J Diabetes; 2015 Aug; 39(4):335-43. PubMed ID: 26233724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Update on insulin therapy for type 2 diabetes.
    Donner T; Muñoz M
    J Clin Endocrinol Metab; 2012 May; 97(5):1405-13. PubMed ID: 22442275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.